The difference in total HEI-2015 scores between the insulin-taking group and the healthy group (β = −7.5 ± 2.4, p = 0.003) was not only statistically significant but also meaningful to health because the difference was large enough to reduce the risk of abdominal obesity [23]. This evidence concerns the gene INS and Abdominal obesity.